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to understand the etiology of complex neurodevelopmental disorders arising from rare missense variants in synaptic genes.
INTRODUCTION
classified as likely pathogenic according to the ACMG guidelines (Richards et al, 2015) . This variant has 155 not been observed in gnomad V2.1.1 156 (https://gnomad.broadinstitute.org/gene/ENSG00000149571?dataset=gnomad_r2_1; 248436 alleles), secondary antibodies diluted in PBS with 3% BSA for 45 minutes. After rinsing, coverslips were mounted 177 in Fluoromount-G (Southern Biotech Cat# 0100-01). For surface labelling, live neurons were incubated in 178 serum-free media at 37˚C in a 5% CO2 incubator with chicken-anti-FLAG for 20 minutes. After initial 179 incubation, neurons were fixed, permeabilized and stained as above. Neuron cultures were prepared as previously described (Martin et al., 2015; Basu et al., 2017) .
205
Briefly, rat cortical astrocytes were plated to glass coverslips coated with 0.03mg/ml (~7.5μg/cm 2 ) of 206 PureCol (Advanced Biomatrix, Cat# 5005) and grown to confluence in glia feeding media: MEM (GIBCO 
218
ECM830, Harvard Apparatus Cat# 45-0002) using the appropriate plasmids and plated at 1x10 5 cells/well 219 onto glia coated coverslips in a standard 12-well plate. Neurons were kept in a 37˚C incubator 220 maintained with 5% CO2. A few hours after plating, the neuron plating media was replaced with 
233
SPO only (originating from interneurons) and VGluT1 + SPO co-labelled puncta (originating from DG 234 neurons) were counted along CA1 dendrites and the density was calculated as the number of puncta per 235 length of dendrite. Analysis was performed blind to condition.
237
Neuron/HEK293 co-culture assays 238 Neuron-HEK293 co-cultures were prepared according to an established method (Biederer and 239 Scheiffele, 2007) . Briefly, P0 rat hippocampal neurons were plated to poly-D-lysine (PDL; 10μg/cm 2 ;
240
Millipore Cat# A-003-E) coated coverslips at 5x10 4 neurons per well in a 24-well plate. HEK293T cells 241 (ATCC Cat# CRL-3216; RRID: CVCL_0063) were transfected with either GFP-pBOS, GFP-pBOS + FLAG-
242
Neuroligin-1 pCDNA, GFP-pBOS + FLAG-Neurexin-1b-AS4(-)-pCDNA or GFP-pBOS + FLAG-Kirrel3-pBOS 243 (wild-type) 24 hours before seeding to neurons. In one condition for the presynaptic assay, the neurons 244 were electroporated with FLAG-Kirrel3-pBOS before plating.
245
Test for pre-synapse induction: Transfected HEK293 cells were seeded to 6 DIV neurons at 3x10 4 246 cells per well. 24 hours later co-cultures were fixed and immunostained with mouse-anti-FLAG, guinea 247 pig-anti-VGluT1 and goat-anti-GFP. Transfected HEK293 cells in proximity to VGluT1 positive axons were imaged and analyzed. To determine the presynaptic hemisynapse density, the total area of VGluT1 puncta on or within 0.5μm of the edge of each HEK293 cell was quantified and normalized to the total 250 area of the cell in ImageJ. Analysis was performed blind to condition.
251
Test for post-synapse induction: Transfected HEK293 cells were seeded to 14 DIV neurons at 252 3x10 4 cells per well. 24 hours later co-cultures were fixed and immunostained with mouse-anti-FLAG, 
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To accomplish our goal, we needed to unambiguously identify CA1 neurons and DG synapses in It is possible Kirrel3 interactions directly instruct neurons to recruit synaptic components at axon-dendrite contact between DG and CA1 neurons, and thereby increase the chance that synapses 368 will form via other molecules. Thus, we next tested if Kirrel3 expression increases axon-dendrite 369 contacts. Tools to identify endogenously-expressing Kirrel3 positive and negative axons in culture are 370 not available, so we cultured neurons from Kirrel3 knockout mice and transfected Kirrel3 in a controlled 371 manner. Knockout neurons were co-transfected with GFP and Kirrel3 and mixed with knockout neurons 372 transfected with either mCherry, or mCherry and Kirrel3. Thus, while in both conditions GFP-labelled 373 neurons expressed Kirrel3: in one condition they were contacted by mCherry axons that were Kirrel3 374 negative, and in the other condition they were contacted by mCherry axons that were Kirrel3 positive.
375
Quantification of the overlap between GFP dendrites and mCherry axons revealed a similar amount of 376 axon-dendrite overlap regardless of whether the axons expressed Kirrel3 or not ( Fig. 2A-2B (Graf et al., 2004) . Interestingly, we find that when HEK293 cells express 390 Kirrel3, the neurons form neither pre-nor post-synapses with HEK293 cells, though both of our positive controls (Neurexin-1 and Neuroligin-1) functioned as expected ( Fig. 3A-3D ; Pre-synapses: Kruskal-Wallis Neurexin-1 p=0.0252). Because Kirrel3 expression specifically induces DG synapses, we also conducted 395 this assay using the DG-specific marker synaptoporin instead of the generic marker VGluT1.
396
Unfortunately, we find synaptoporin is not reliably expressed in the 7 DIV neurons used for this assay.
397
We circumvented this limitation by transfecting extra Kirrel3 into hippocampal neurons and then 398 quantifying the density of presynaptic puncta on Kirrel3-expressing HEK293 cells contacting Kirrel3-399 transfected axons. We found that this still had no effect on the density of pre-synapses formed onto 400 HEK293 cells ( Fig. 3A-B ; Kruskal-Wallis test with Dunn's multiple comparisons GFP vs Kirrel3 neuron and 401 HEK293 expression p>0.9999). In conclusion, we find Kirrel3 is not sufficient to induce synapses when 402 expressed in a non-neuronal cell. Taken together, our work indicates that Kirrel3's synaptogenic function 403 requires both trans-cellular Kirrel3 binding and interactions with an additional co-factor(s) present in 404 CA1 neurons but not in HEK293 cells.
406
Kirrel3 missense variants appropriately traffic to synapses and the cell surface 407 Thus far, we used our in vitro gain-of-function assay to identify basic mechanistic principles of 408 Kirrel3 signaling during synapse formation. Next, we tested if and how disease-associated Kirrel3 409 missense variants affect its function. Accordingly, we cloned six missense variants identified as possible 410 risk factors for neurodevelopmental disorders (Fig. 4A ; Table 1 ; Bhalla, et al., 2008; De Rubeis, et al., 411 2014; Iossifov, et al., 2014; Yuen, et al., 2016) . These variants span the length of the Kirrel3 protein and 412 are fully conserved between the mouse and human proteins, which share 98% amino acid identity 413 (Gerke et al., 2005) . Most variants are found in patients with both autism and intellectual disability. One male patient with developmental delay, intellectual disability, ADHD, and obesity (see methods for 416 complete description).
417
Missense variants can impair the function of synaptic molecules by altering their trafficking or 418 surface expression (Chih et al., 2004; Zhang et al., 2009; Jaco et al., 2010) . Thus, we first tested if Kirrel3 419 variants are expressed on the cell surface similar to wild-type Kirrel3. We transfected CHO cells with 420 Kirrel3 plasmids containing an extracellular FLAG tag that does not interfere with Kirrel3 homophilic 421 binding (Martin et al., 2015) . The cells were live-labelled with chicken-anti-FLAG antibodies to label 422 Kirrel3 protein on the extracellular surface. Then, cells were fixed, permeabilized, and incubated with 423 mouse-anti-FLAG antibodies to label intracellular Kirrel3 (Fig. 4B ). The ratio of extracellular to 424 intracellular Kirrel3 was quantified for individual cells. We find the relative intensities of extracellular to 425 intracellular FLAG-Kirrel3 are indistinguishable between groups, indicating that all six missense variants 426 are appropriately trafficked to the cell surface similar to wild-type Kirrel3 (Fig. 4C ; one-way ANOVA 427 F(6,56)=0.9878, p=0.4424).
428
Wild-type Kirrel3 localizes at or near excitatory synapses (Martin et al., 2015; Roh et al, 2017) .
429
Thus, we tested if Kirrel3 missense variants also localize to the cell surface at synapses in neurons. We 430 expressed mCherry-2A-FLAG Kirrel3 and missense variants in cultured neurons and determined their 431 localization relative to synapses by co-staining for surface-expressed FLAG, VGluT1, and PSD-95 ( Fig. 4D ).
432
All Kirrel3 variants display a punctate expression pattern and are found in close proximity to juxtaposed 433 VGluT1/PSD-95 puncta at similar rates ( Fig. 4E; Kruskal 
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We next tested the ability of each variant to induce DG pre-synapses when ectopically expressed 438 in CA1 neurons compared to wild-type (as shown Figure 1D ). Importantly, we found that four of the six disease-associated variants (R161H, R205Q, R336Q and V731F) significantly attenuate Kirrel3 mediated domain may alter downstream signaling. It is not yet possible to test Kirrel3 intracellular signaling 464 because very little is known about Kirrel3's intracellular interactions or signaling mechanisms. Therefore,
465
we tested the ability of each missense variant to mediate homophilic binding in trans using an 466 established CHO cell aggregation assay. CHO cells do not endogenously express appreciable levels of 467 Kirrel3 (Fig. 6A) and when mixed in suspension they do not normally form cell aggregates (Fig. 6B-C) . In 468 contrast, CHO cells transfected with wild-type Kirrel3 form multicellular aggregates consistent with 469 Kirrel3 undergoing homophilic, trans-cellular binding ( Fig. 6B-C ; Martin et al., 2015) . After testing each 470 variant, we find that cells transfected with R40W, R161H, R336Q and M673I aggregate similarly to wild-471 type Kirrel3, but the R205Q and V731F missense variants do not induce cell aggregation (Fig. 6C 
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Collectively these results indicate that missense variants impact Kirrel3 function in distinct ways: some 482 attenuate Kirrel3 mediated trans-cellular interactions, while others maintain an ability to mediate 483 contact recognition but still fail to induce synaptogenesis strongly implicating additional unidentified 484 signaling mechanisms.
486

DISCUSSION
Kirrel3 functions in synapse development as a homophilic cell-recognition tag
Kirrel3 is an emerging hotspot for rare variants linked to neurodevelopmental disorders (Bhalla 559 et al, 2008; Kaminsky et al, 2011; Ben-David and Shifman, 2012; Guerin et al, 2012; Michaelson et al, 560 2012; Neale et al, 2012; Talkowski et al, 2012; Iossifov et al, 2014; Rubeis et al, 2014; Wang et al, 2016;  561 Yuen et al, 2016; Li et al, 2017; Guo et al, 2019; Leblond, et al, 2019) . Here we provide the first 562 functional evidence demonstrating that Kirrel3 variants could cause disease.
563
Interestingly, not all of the missense variants studied present a phenotype. Our newly reported 564 M673I variant performs similar to wild-type Kirrel3 in all of the assays presented here. While this 565 negative result could mean this particular variant is not disease causing, it is also possible that the 566 variant requires a second mutation in another unidentified gene to impair its function or that our 
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Most disease-associated Kirrel3 variants are rare, spontaneous mutations for which patients are 575 heterozygous. If these variants cause disease then Kirrel3 is likely haploinsufficient and/or disease-576 associated variants act as dominant negative proteins. In support of haploinsufficiency, an interstitial 577 deletion on part of chromosome 11, which leads to a complete loss of one copy of Kirrel3 along with 578 other genes, is associated with Jacobsen syndrome, a developmental disorder with frequent 579 neurological symptoms including ASD, epilepsy, and intellectual disability (Guerin et al., 2012) .
580
Furthermore, Kirrel3 has a pLI score, a probability measure that a gene is intolerant to heterozygous loss 581 of function variation, of 0.97 suggesting haploinsufficiency for loss of function variants (gnomAD database https://gnomad.broadinstitute.org/; Lek et al, 2016) . On the other hand, we find that all partners. Future work is needed to determine the precise mechanism of Kirrel3 and each variant in vivo,
586
but results from this study provide a critical foundation that Kirrel3 variants are likely bona fide disease 587 risk factors.
588
The study of Kirrel3 has strong potential to contribute to our broader understanding of the cellular 
